Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
from fta.dot.gov
More from this publisher
25.10.2013
Views
49 CFR Part 40 Updated August 31, 2009
- Page 322 and 323: connection between marijuana smokin
- Page 324 and 325: Opiates (Narcotics) Fact Sheet Opia
- Page 326 and 327: Phencyclidine (PCP) Fact Sheet Phen
- Page 328 and 329: Appendix G Questions and Answers
- Page 330 and 331: ecipient, and someone other than th
- Page 332 and 333: Q. Can transit operators receive wa
- Page 334 and 335: Q. If an employee changed jobs prio
- Page 336 and 337: Q. How much training are employers
- Page 338 and 339: acceptable for the company-required
- Page 340 and 341: Q. In a post-accident situation req
- Page 342 and 343: employees and 50 non-DOT employees,
- Page 344 and 345: Q: What actual address is required
- Page 346 and 347: Q: Can a split specimen be sent to
- Page 348 and 349: actual employee of the employer may
- Page 350 and 351: Q: Must collectors, BATs, STTs, MRO
- Page 352 and 353: an observer, or a monitor for co-wo
- Page 354 and 355: Q: If a collector makes an error on
- Page 356 and 357: Appendix H Terms and Definitions
- Page 358 and 359: indirectly, one controls or has the
- Page 360 and 361: Confirmation validity test Confirme
- Page 362 and 363: These terms include any designee of
- Page 364 and 365: Medical Review Officer (MRO) A pers
- Page 366 and 367: Random test Reason to believe Reaso
- Page 368 and 369: Safety-sensitive function Any of th
- Page 370 and 371: trolley bus, or vessel. A “mass t
- Page 374 and 375: TITLE 49: TRANSPORTATION PART 40 -
- Page 376 and 377: § 40.187 What does the MRO do with
- Page 378 and 379: § 40.397 When does the Director ma
- Page 380 and 381: Page 7 of 100 Confirmatory validity
- Page 382 and 383: Page 9 of 100 § 40.7 How can you g
- Page 384 and 385: Page 11 of 100 (C) You maintain no
- Page 386 and 387: Page 13 of 100 §40.35—Informatio
- Page 388 and 389: §40.103—Processing blind specime
- Page 390 and 391: Page 17 of 100 (b) (1) In the rare
- Page 392 and 393: Page 19 of 100 (3) If the specimen
- Page 394 and 395: Page 21 of 100 (7) You must then en
- Page 396 and 397: Page 23 of 100 § 40.85 What drugs
- Page 398 and 399: Page 25 of 100 (v) Invalid result,
- Page 400 and 401: Page 27 of 100 (4) Adulterated blin
- Page 402 and 403: Page 29 of 100 (i) If you became an
- Page 404 and 405: Page 31 of 100 (d) If you cancel a
- Page 406 and 407: Page 33 of 100 affecting the perfor
- Page 408 and 409: Page 35 of 100 (1) If you determine
- Page 410 and 411: Page 37 of 100 (i) You must not acc
- Page 412 and 413: Page 39 of 100 long-term medical co
- Page 414 and 415: §40.97—Laboratory handling of te
- Page 416 and 417: Page 43 of 100 § 40.187 What does
- Page 418 and 419: Page 45 of 100 (b) As an employee,
- Page 420 and 421: Page 47 of 100 (2) Acute or tempora
49 CFR Part 40<br />
Updated August 31, 2009
Change language